Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemia

American Journal of Clinical Pathology

Volumn 105, Issue 4, 1996, Pages 458-467

  Finn, William G ^a,b   Thangavelu, Maya ^a   Yelavarthi, Krishna K ^a   Goolsby, Charles L ^a   Tallman, Martin S ^a   Traynor, Ann ^a   Peterson, Loann C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Chronic lymphocytic leukemia; Cytogenetics; Immunophenotype

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC HETEROGENEITY; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MALE; MORPHOLOGY; PRIORITY JOURNAL;

EID: 0029915196     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.4.458     Document Type: Article

References (28)

1. Bennett JM, Catovsky D, Daniel M-T, et al. Proposals for the classification of chronic (mature) B and T lymphoid malignancies. J Clin Pathol 1989;42:567-584.
2. Geisler CH, Larsen JK, Hansen NE, et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991;78:1795-1802.
3. Marti GE, Zenger V, Caproaso NE, et al. Antigenic expression of B-cell chronic lymphocytic leukemic lymphocytes. Anal Quant Cytol Histol 1989;11:315-323.
4. Almasri NM, Duque RE, Iturraspe J, Everett E, Braylan RC. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol 1992;40:259-263.
5. Witzig TE, Li C-Y, Tefferi A, Katzmann JA. Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia. Am J Clin Pathol 1994;101:312-317.
6. Peterson LC, Bloomfield CD, Sundberg RD, Gajl-Peczalska KJ, Brunning RD. Morphology of chronic lymphocytic leukemia and its relationship to survival. Am J Med 1975;59:316-324.
7. Peterson LC, Bloomfield CD, Brunning RD. Relationship of clinical staging and lymphocyte morphology to survival in chronic lymphocytic leukaemia. Br J Haematol 1980;45:563-567.
8. Kay NE, Peterson L. Heterogeneity of CD5 membrane expression on B-chronic lymphocytic leukemia cells. Leuk Lymphoma 1991;5:49-55.
9. Tallman MS, Hakimian D, Zanzig C, et al. Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia. J Clin Oncol 1995;13:983-988.
10. Keating MJ, Kantarjian H, O'Brien S, et al. Fludarabine: A new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. J Clin Oncol 1991;9:44-49.
11. Juliusson G, Oscier DG, Fitchett M, et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 1990;323:720-724.
12. Peterson LC, Lindquist LL, Church S, Kay NE. Frequent clonal abnormalities of chromosome band 13q14 in B-cell chronic lymphocytic leukemia: Multiple clones, subclones, and non-clonal alterations in 82 midwestern patients. Genes Chromosom Cancer 1992;4:273-280.
13. Juliusson G, Rober K-H, Ost A, et al. Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. Blood 1985;65:134-141.
14. Criel A, Wlodarska I, Meeus P, et al. Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias. Br J Haematol 1994;87:523-528.
15. Que TH, Marco G, Ellis J, et al. Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Analysis by stage, immunophenotype, and morphology. Blood 1993;82:571-575.
16. Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-234.
17. ISCN 1991. Cancer Cytogenetics (Supplement to an International System for Human Cytogenetic Nomenclature). Basel, Switzerland: S. Karger, 1991.
18. Pinkel D, Straum T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Nat Acad Sci USA 1986;83:2934-2938.
19. Hanson CA, Gribbin TE, Schnitzer B, et al. CD11c (Leu-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Blood 1990;76:2360-2367.
20. Wormsley SB, Baird SM, Gadol N, Rai KR, Sobol RE. Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lympoid leukemia immunophenotypes. Blood 1990;76:123-130.
21. Miller ML, Fishleder AJ, Tubbs RR. The expression of CD22 (Leu 14) and CD11c (Leu M5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis. Am J Clin Pathol 1991;96:100-108.
22. Molica S, Dattilo A, Mannella A, Levato D. CD11c expression in B-cell chronic lymphocytyic leukemia. A comparison of results obtained with different monoclonal antibodies. Haematologica 1994;79:452-455.
23. Kay NE, Suen R, Ranheim E, Peterson LC. Confirmation of Rb gene defects in B-CLL clones and evidence for variable predominance of the Rb defective cells within the CLL clone. Br J Haematol 1993;84:257-264.
24. Hawthorn LA, Chapman R, Oscier D, Cowell JK. The consistent 13q14 translocation breakpoint seen in chronic B-cell leukemia (BCLL) involves deletion of the D13S25 locus which lies distal to the retinoblastoma predisposition gene. Oncogene 1993;8: 1415-1419.
25. Chapman RM, Corcoran MM, Gardiner A, et al. Frequent homozygous deletions of the D13S25 locus in chromosome region 13q14 defines the location of a gene critical in leukaemogenesis in chronic B-cell lymphocytic leukaemia. Oncogene 1994;9: 1289-1293.
26. Criel A, Billiet J, Vandenberghe E, et al. Leukaemic intermediate lymphocytic lymphomas: Analysis of 12 cases diagnosed by morphology. Leuk Lymphoma 1992;8:381-387.
27. Segal GH, Masih AS, Fox AC, et al. CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangements have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood 1995;85:1570-1579.
28. Ohno H, Takimoto G, McKeithan TW. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 1990;60:991-997.